Vice President Marketing, Oncology

Illinois, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Life Sciences, Medical DiagnosticsIndustries

Requirements

Candidates should have over 10 years of progressive marketing experience, with significant time in senior roles within oncology, diagnostics, life sciences, or related healthcare technology fields. Deep scientific and market expertise in oncology, including diagnostics and genomics, is required, along with a strong understanding of clinical workflows. Exceptional storytelling and communication skills to translate complex scientific concepts into clear value propositions are essential. Proven commercial strategy development with a track record of driving revenue growth and adoption metrics is necessary. Experience building, managing, and mentoring high-performing teams, along with outstanding cross-functional leadership and project management skills in a matrixed organization, is expected. An entrepreneurial and results-oriented mindset is also required.

Responsibilities

The Vice President of Marketing will architect the end-to-end marketing strategy for Oncology solutions, including market segmentation, product positioning, and messaging. They will drive commercial growth by developing and executing integrated marketing plans in partnership with Sales leadership to increase market share and achieve business objectives. Responsibilities include crafting compelling narratives and campaigns to generate demand and establish thought leadership, fostering cross-functional alignment with Product, R&D, Sales, and Medical Affairs, and overseeing the creation of impactful content like clinical publications, white papers, and sales tools. The role also involves establishing a data-driven marketing culture by defining, tracking, and reporting on KPIs and marketing ROI, and leading and inspiring a high-performing marketing team.

Skills

Marketing strategy

Market segmentation

Product positioning

Messaging

Campaign management

Multi-channel marketing

Oncology

Genomics

Clinical audience targeting

Revenue growth

Cross-functional leadership

Sales alignment

Commercial growth

Healthcare marketing

AI/precision medicine

Storytelling

Campaign execution

Brand positioning

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free